Human milk fortifier composition
AssigneeSociete des Produits Nestle S.A.
InventorsMichael Affolter, Sean Christopher Austin, Clara Lucia Garcia-Rodenas
Life of this patent
Estimating the term…
Abstract
The present invention relates to a preterm human milk fortifier composition, more specifically to a preterm milk fortifier composition providing 2′-FL and/or LNFP-I in amounts that are missing in human milk of women who gave birth to a preterm infant. In particular the present invention relates to a fortifier composition designed for infants as a supplement to preterm human breast milk at the time the infant leaves the hospital (discharge) and after. The invention furthermore relates to the use of said preterm human milk fortifier composition.
Claims8
A human milk fortifier composition consisting essentially of:
- (i) at least one ingredient selected from the group consisting of:
- ingredients providing 2′-fucosyllactose (2′-FL) in an amount ranging from 10 to 250 mg/g of the human milk fortifier composition;
- ingredients providing lacto-N-fucosylpentaose-I (LNFP-I) from 50 to 200 mg/g of the human milk fortifier composition;
- and mixtures thereof;
- (ii) one or more additional ingredients selected from the group consisting of:
- ingredients providing copper;
- ingredients providing selenium;
- ingredients providing zinc;
- ingredients providing alpha-lactalbumin;
- ingredients providing casein;
- ingredients providing lactoferrin;
- ingredients providing gamma-tocopherol;s
- ingredients providing nicotinic acid;
- ingredients providing retinol;
- ingredients providing difucosyl lacto-N-hexaose-a (DFSLTNH);
- ingredients providing monofucosyl lacto-N-hexaose-III (FSLTNH3);
- ingredients providing 6′-galactosyl lactose (GSLT6);
- ingredients providing lacto-N-neotetraose (LnNT);
- ingredients providing lacto-N-tetraose (LNT);
- ingredients providing 6′-sialyllactose (6′SL);
- and
- ingredients providing sialyllactose-N-tetraose-c (SLTNTC);
- and mixtures thereof;
- and
- (iii) one or more further additional ingredients selected from the group consisting of:
- preservatives, probiotics, anti-oxidants, buffers, colorants, flavours, thickening agents, stabilizers, and other excipients or processing aids;
- wherein the human milk fortifier composition is in the form of a powder.
A package comprising a human milk fortifier composition, wherein the package is a single-dosing device or a multi-dosing device,
- the human milk fortifier composition consisting essentially of:
- (i) at least one ingredient selected from the group consisting of:
- ingredients providing 2′-fucosyllactose (2′-FL) in an amount ranging from 10 to 250 mg/g of the human milk fortifier composition;
- ingredients providing lacto-N-fucosylpentaose-I (LNFP-I) from 50 to 200 mg/g of the human milk fortifier composition;
- and mixtures thereof;
- (ii) one or more additional ingredients selected from the group consisting of:
- ingredients providing copper;
- ingredients providing selenium;
- ingredients providing zinc;
- ingredients providing alpha-lactalbumin;
- ingredients providing casein;
- ingredients providing lactoferrin;
- ingredients providing gamma-tocopherol;
- ingredients providing nicotinic acid;
- ingredients providing retinol;
- ingredients providing difucosyl lacto-N-hexaose-a (DFSLTHN);
- ingredients providing monofucosyl lacto-N-hexaose-III (FSLTNH3);
- ingredients providing 6′-galactosyl lactose (GSLT6);
- ingredients providing lacto-N-neotetraose (LnNT);
- ingredients providing lacto-N-tetraose (LNT);
- ingredients providing 6′-sialyllactose (6′SL);
- and
- ingredients providing sialyllactose-N-tetraose-c (SLTNTC);
- and mixtures thereof;
- and
- (iii) one or more further additional ingredients selected from the group consisting of:
- preservatives, probiotics, anti-oxidants, buffers, colorants, flavours, thickening agents, stabilizers, and other excipients or processing aids;
- wherein the human milk fortifier composition is in the form of a powder.
A human milk fortifier composition consisting of minerals, vitamins, milk proteins, and human milk oligosaccharides (HMOs), wherein at least one of 2′-fucosyllactose (2′-FL) in an amount ranging from 10 to 250 mg/g of the human milk fortifier composition or lacto-N-fucosylpentaose-I (LNFP-I) from 50 to 200 mg/g of the human milk fortifier composition is part of the HMOs,
- wherein the human milk fortifier composition is in the form of a powder.
Dependencies are inferred from the claim text.